AI Drug Discovery
What Is AI Drug Discovery?
A scientific guide to how artificial intelligence supports target discovery, structural biology, molecular design and candidate prioritization.
Read Insight →Knowledge & Insights
Perspectives on AI, structural biology and computational approaches shaping modern drug discovery.
All Topics
AI Drug Discovery
Structural Intelligence
Structure Prediction
Molecular Discovery
Protein & Biologic Design
Enterprise R&D
Featured Insight
What Is Structural Intelligence in Drug Discovery?
Structural intelligence extends beyond structure prediction to interpret molecular structure for discovery decisions — from binding-site detection and druggability analysis to candidate evaluation.
Read Insight →AI Drug Discovery
AI Drug Discovery
AI Drug Discovery Platforms: An Evaluation Framework
What pharmaceutical and biotech teams should evaluate when selecting computational discovery infrastructure.
Read Insight →Structural Intelligence
Structural Intelligence
Structure Prediction vs Structural Intelligence
Understanding the difference between generating a protein structure and interpreting it for drug discovery decisions.
Read Insight →
Structural Intelligence
From Protein Structure to Drug Candidate
A structure-guided discovery workflow from sequence through candidate prioritization for experimental testing.
Read Insight →Molecular Discovery
Molecular Discovery
What Is Molecular Docking?
How molecular docking predicts ligand-protein interactions and supports structure-based drug design.
Read Insight →
Molecular Discovery
Binding Pocket Detection and Druggability Analysis
How computational analysis identifies and evaluates potential binding sites for therapeutic intervention.
Read Insight →Protein & Biologic Design
Biologic Design
Nanobodies vs Antibodies vs Mini-Binders
Comparing therapeutic modalities: size, stability, manufacturing and target accessibility considerations.
Read Insight →Enterprise R&D
Enterprise R&D
What Is a No-Code AI Drug Discovery Platform?
How visual interfaces enable scientists to access integrated computational discovery workflows.
Read Insight →
Enterprise R&D
Cloud vs On-Premise AI for Pharmaceutical R&D
Deployment architecture considerations for proprietary drug discovery data and computational workflows.
Read Insight →
Enterprise R&D
Protecting Intellectual Property in AI Drug Discovery
Data governance, infrastructure control and contractual considerations for proprietary research.
Read Insight →